Literature DB >> 17581331

Influence of the centrifuge time of primary plasma tubes on routine coagulation testing.

Giuseppe Lippi1, Gian Luca Salvagno, Martina Montagnana, Franco Manzato, Gian Cesare Guidi.   

Abstract

Preparation of blood specimens is a major bottleneck in the laboratory throughput. Reliable strategies for reducing the time required for specimen processing without affecting quality should be acknowledged, especially for laboratories performing stat analyses. The present investigation was planned to establish a minimal suitable centrifuge time for primary samples collected for routine coagulation testing. Five sequential primary vacuum tubes containing 0.109 mol/l buffered trisodium citrate were collected from 10 volunteers and were immediately centrifuged on a conventional centrifuge at 1500 x g, at room temperature for 1, 2, 5, 10 and 15 min, respectively. Hematological and routine coagulation testing, including prothrombin time, activated partial thromboplastin time and fibrinogen, were performed. The centrifugation time was inversely associated with residual blood cell elements in plasma, especially platelets. Statistically significant variations from the reference 15-min centrifuge specimens were observed for fibrinogen in samples centrifuged for 5 min at most and for the activated partial thromboplastin time in samples centrifuged for 2 min at most. Meaningful biases related to the desirable bias were observed for fibrinogen in samples centrifuged for 2 min at most, and for the activated partial thromboplastin time in samples centrifuged for 1 min at most. According to our experimental conditions, a 5-10 min centrifuge time at 1500 x g may be suitable for primary tubes collected for routine coagulation testing.

Entities:  

Mesh:

Year:  2007        PMID: 17581331     DOI: 10.1097/MBC.0b013e3281eec945

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  6 in total

Review 1.  Pre-analytic variability in cardiovascular biomarker testing.

Authors:  Roberto Cemin; Massimo Daves
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

2.  Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+).

Authors:  Marie Méan; Drahomir Aujesky; Bernhard Lämmle; Christiane Gerschheimer; Sven Trelle; Anne Angelillo-Scherrer
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

Review 3.  Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.

Authors:  Viswam S Nair; Colin C Pritchard; Muneesh Tewari; John P A Ioannidis
Journal:  Am J Epidemiol       Date:  2014-06-24       Impact factor: 4.897

4.  Plasma centrifugation does not influence thrombin-antithrombin and plasmin-antiplasmin levels but determines platelet microparticles count.

Authors:  Ewa Stępień; Krzysztof Gruszczyński; Przemysław Kapusta; Artur Kowalik; Iwona Wybrańska
Journal:  Biochem Med (Zagreb)       Date:  2015-06-05       Impact factor: 2.313

Review 5.  Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories.

Authors:  A Magnette; M Chatelain; B Chatelain; H Ten Cate; F Mullier
Journal:  Thromb J       Date:  2016-12-12

6.  Influence of centrifugation conditions on the results of 77 routine clinical chemistry analytes using standard vacuum blood collection tubes and the new BD-Barricor tubes.

Authors:  Janne Cadamuro; Cornelia Mrazek; Alexander B Leichtle; Ulrike Kipman; Thomas K Felder; Helmut Wiedemann; Hannes Oberkofler; Georg M Fiedler; Elisabeth Haschke-Becher
Journal:  Biochem Med (Zagreb)       Date:  2017-11-24       Impact factor: 2.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.